PALISADE BIO

Our mission is to develop and commercialize novel therapeutics that target diseases resulting from a loss of gastrointestinal barrier integrity... Leveraging more than three decades of research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption... Our lead program LB1148 is being investigated in a Phase 2 study to evaluate its effects on intra-abdominal adhesions and return of gastrointestinal function in subjects undergoing elective bowel resection (PROFILE).

Also known as: Palisade, Palisade Bio, Inc.

Primary location: Carlsbad United States